Outset Medical Inc (OM)
0.7919
-0.07
(-8.01%)
USD |
NASDAQ |
Nov 15, 16:00
0.7935
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Research and Development Expense (TTM): 43.04M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 43.04M |
| June 30, 2024 | 50.98M |
| March 31, 2024 | 56.15M |
| December 31, 2023 | 57.31M |
| September 30, 2023 | 56.22M |
| June 30, 2023 | 53.20M |
| March 31, 2023 | 51.82M |
| December 31, 2022 | 48.86M |
| September 30, 2022 | 48.82M |
| Date | Value |
|---|---|
| June 30, 2022 | 45.49M |
| March 31, 2022 | 40.00M |
| December 31, 2021 | 36.74M |
| September 30, 2021 | 33.12M |
| June 30, 2021 | 32.56M |
| March 31, 2021 | 30.58M |
| December 31, 2020 | 28.85M |
| September 30, 2020 | 27.70M |
| June 30, 2020 | 24.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
24.23M
Minimum
Jun 2020
57.31M
Maximum
Dec 2023
42.54M
Average
44.27M
Median
Research and Development Expense (TTM) Benchmarks
| Paragon 28 Inc | 28.43M |
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |